Advertisement
Advertisement

IVF

I

INVO Fertility, Inc. Common Stock

0.63
USD
Sponsored
-0.05
-8.06%
Mar 25, 16:00 UTC -4
Closed
exchange

Pre-Market

0.61

-0.01
-2.29%

IVF Earnings Reports

Positive Surprise Ratio

IVF beat 4 of 11 last estimates.

36%

Next Report

Date of Next Report
Apr 28, 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.95M
/
-$0.55
Implied change from Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q4 24 (Revenue/ EPS)
-61.83%
/
-99.91%

INVO Fertility, Inc. Common Stock earnings per share and revenue

On --, IVF reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, 2 analysts forecast an EPS of -0.55 USD, with revenue projected to reach 1.95 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
IceCure Medical Ltd. Ordinary Shares
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.07
Surprise
-52.51%
logo
Lifeward Ltd. Ordinary Shares
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$1.10
Actual
-$3.60
Surprise
-226.80%
logo
SeaStar Medical Holding Corporation Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.07
Actual
-$0.80
Surprise
+25.28%
logo
Healthy Choice Wellness Corp.
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.05
Surprise
+1.96%
logo
Aclarion, Inc. Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$3.67
Actual
-$2.54
Surprise
+30.83%
logo
HealthEquity, Inc
Report Date
Mar 17, 2026 For Q4 26
Estimate
$0.90
Actual
$0.95
Surprise
+4.51%
logo
The Oncology Institute, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.06
Surprise
+33.99%
logo
The Beauty Health Company Class A Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.06
Surprise
-14.29%
logo
Sera Prognostics, Inc. Class A Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.16
Surprise
+17.44%
logo
DocGo Inc. Common Stock
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.13
Actual
-$1.37
Surprise
-920.10%
FAQ
For Q-- --, INVO Fertility, Inc. Common Stock reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Apr 28, 2026.
Based on 2 analysts, INVO Fertility, Inc. Common Stock is expected to report EPS of -$0.55 and revenue of $1.95M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement